Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000820912 | SCV000961649 | uncertain significance | Spermatogenic failure 18; Ciliary dyskinesia, primary, 37 | 2022-03-13 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with DNAH1-related conditions. ClinVar contains an entry for this variant (Variation ID: 663109). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant is present in population databases (rs761794737, gnomAD 0.007%). This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 2978 of the DNAH1 protein (p.Tyr2978Cys). |
Ambry Genetics | RCV004029053 | SCV003745879 | uncertain significance | not specified | 2024-11-13 | criteria provided, single submitter | clinical testing | The c.8933A>G (p.Y2978C) alteration is located in exon 56 (coding exon 55) of the DNAH1 gene. This alteration results from a A to G substitution at nucleotide position 8933, causing the tyrosine (Y) at amino acid position 2978 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV004792536 | SCV005409240 | uncertain significance | not provided | 2023-10-11 | criteria provided, single submitter | clinical testing |